Related Experiment Video

Updated: Aug 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Therapeutic strategies for cardiogenic shock, 2006

Troy C Ellis1, Eli Lev, Naji F Yazbek

  • 1Department of Cardiology, Methodist Debakey Heart Center, 6565 Fannin, F1090, Houston, TX 77030, USA.

Current Treatment Options in Cardiovascular Medicine
|January 13, 2006
PubMed

Insights

Cardiogenic shock treatment involves prompt reperfusion and hemodynamic support. Newer strategies target systemic inflammation alongside traditional therapies to improve outcomes for this high-mortality condition.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock, a severe complication of myocardial infarction, carries a high mortality rate.
  • Current treatments focus on reperfusion and hemodynamic support, including revascularization and pharmacologic agents.
  • The efficacy of some traditional agents for survival benefit remains unproven, relying heavily on clinical experience.

Purpose of the Study:

  • To review recent advances in understanding and treating cardiogenic shock.
  • To highlight the role of systemic inflammation in cardiogenic shock development.
  • To discuss emerging and traditional therapeutic strategies.

Main Methods:

  • Review of recent evidence on cardiogenic shock.
  • Analysis of the role of inflammatory pathways (iNOS, complement, cytokines).
  • Evaluation of traditional and novel therapeutic interventions.

Main Results:

  • Systemic inflammation, involving inducible nitric oxide synthase (iNOS), complement activation, and cytokine cascades, contributes to cardiogenic shock.
  • Traditional therapies include emergent angiography, revascularization (PCI, CABG), and circulatory assist (IABP).
  • Adjunctive pharmacologic agents like inotropes and vasopressors support hemodynamics but lack proven survival benefits.

Conclusions:

  • Emerging therapeutic strategies incorporate anti-inflammatory agents (e.g., C5 inhibitors, iNOS inhibitors).
  • These newer approaches are being combined with established treatments for cardiogenic shock.
  • Further research is needed to confirm the survival benefits of novel therapeutic strategies.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...